Goldman Sachs Downgrades U.S. Large Cap Biotech Shares To Neutral
More News related to BBH
- Barclays Gets Bullish On US Biotechnology Sector (BBH)
- Goldman Sachs Downgrades U.S. Large Cap Biotech Shares To Neutral
- ETF Movers: Biotech ETFs On the Moves Following ImClone Offer
- ETF Movers 7/28: Financial Select Sector (XLF) Lower, Biotech HOLDRs (BBH) Higher, More...
- ETF Movers 7/22: Semiconductor HOLDRs (SMH) Slammed, KBW Regional Banking (KRE) Weak
Goldman Sachs Downgrades U.S. Large Cap Biotech Shares To Neutral.
Related ETF: Biotech HOLDRs (NYSE: BBH).
Related Categories
DowngradesStocks Mentioned
+1.45Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
